Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nonsteroidal gestagens

Nonsteroidal gestagens

US Patent 6245804 · Granted Jun 12, 2001

Estimated economic value: $340,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicam2015
19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-2015
17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, 2015
15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use th2014
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical p2013
18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical p2013
17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising th2012
18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-e2010
17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, u2009
9-α-substituted estratrienes as selectively active estrogens2008
Non-steroidal progesting2008
8β-hydrocarbyl-substituted estratrienes for use as selective estrogens2008